357 related articles for article (PubMed ID: 15066207)
1. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
[TBL] [Abstract][Full Text] [Related]
2. [Vasonatrin peptide attenuates the enhancement of electrically-induced intracellular calcium transient by isoproterenol in rat cardiac myocytes].
Guo HT; Zhu MZ; Zhang RH; Bi H; Zhang B; Zhang HF; Yu J; Lu SY; Pei JM
Sheng Li Xue Bao; 2004 Jun; 56(3):335-40. PubMed ID: 15224146
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells.
Lu SY; Wang DS; Zhu MZ; Zhang QH; Hu YZ; Pei JM
Life Sci; 2005 May; 77(1):28-38. PubMed ID: 15848216
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes].
Lu SY; Zhu MZ; Guo HT; Yu J; Wei QM
Sheng Li Xue Bao; 2002 Feb; 54(1):7-11. PubMed ID: 11930233
[TBL] [Abstract][Full Text] [Related]
5. [Study on the mechanism of how vasonatrin peptide can attenuate the growth-promoting effect of hypoxia in cardiac fibroblasts].
Yu J; Zhu MZ; Cheng BY; Lu SY; Dong MQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Feb; 19(1):8-11. PubMed ID: 21207845
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
7. [Vasonatrin peptide attenuates hypoxia-induced increase in [Ca(2+)] (i) of culured rat cardiac fibroblasts].
Guo HT; Zhu MZ; Lu SY; Yu J; Dong MQ; Gao Z; Shi PT
Sheng Li Xue Bao; 2001 Aug; 53(4):286-90. PubMed ID: 11930207
[TBL] [Abstract][Full Text] [Related]
8. Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis.
Chen BY; Qu P; Tie R; Zhu MZ; Zhu XX; Yu J
Regul Pept; 2010 Sep; 164(2-3):139-43. PubMed ID: 20619296
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
10. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of atrial natriuretic peptide and its receptor in the lung: effects on perinatal surfactant release.
D'Angelis CA; Holm BA; Lakshminrusimha S; Nickerson PA; Swartz DD; Sokolowski J; Nielsen LC; Ryan RM
Pediatr Res; 2008 Mar; 63(3):239-44. PubMed ID: 18287960
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes.
Nishikimi T; Iemura-Inaba C; Akimoto K; Ishikawa K; Koshikawa S; Matsuoka H
Regul Pept; 2009 Feb; 153(1-3):56-63. PubMed ID: 19027799
[TBL] [Abstract][Full Text] [Related]
13. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
[TBL] [Abstract][Full Text] [Related]
14. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
15. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
16. Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats.
Jin H; Li B; Cunningham B; Tom J; Yang R; Sehl P; Thomas GR; Ko A; Oare D; Lowe DG
J Clin Invest; 1996 Aug; 98(4):969-76. PubMed ID: 8770869
[TBL] [Abstract][Full Text] [Related]
17. Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries.
Woodard GE; Li X; Brown J; Rosado JA
Regul Pept; 2005 Jul; 129(1-3):183-9. PubMed ID: 15927715
[TBL] [Abstract][Full Text] [Related]
18. Presence of functional type B natriuretic peptide receptor in human ocular cells.
Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339
[TBL] [Abstract][Full Text] [Related]
19. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.
Christoffersen C; Bartels ED; Nielsen LB
Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.
Brown LA; Nunez DJ; Wilkins MR
J Clin Invest; 1993 Dec; 92(6):2702-12. PubMed ID: 7902846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
